ITOS - Iteos Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Iteos Therapeutics's activity chart (see below) currently has 65 price targets and 46 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10.52% with an average time for these price targets to be met of 103.5 days.

Most recent stock forecast was given by EVA FORTEA VERDEJO from WELLS FARGO on 07-Aug-2025. First documented stock forecast 18-Aug-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Aug-2025

$11

$0.85 (8.37%)

$12

1 years 2 months 24 days ago
(07-Aug-2025)

0/6 (0%)

$0.87 (8.59%)

Hold Since 22-Jul-2025

$10

$-0.15 (-1.48%)

$9

1 years 3 months 9 days ago
(22-Jul-2025)

3/6 (50%)

$-0.12 (-1.19%)

240

Buy Since 18-Aug-2020

$12

$1.85 (18.23%)

$18

1 years 5 months 3 days ago
(28-May-2025)

2/8 (25%)

$1.94 (19.28%)

281

Buy Since 05-May-2021

$46

1 years 5 months 17 days ago
(14-May-2025)

1/11 (9.09%)

$38.9 (547.89%)

198

Buy Since 16-Mar-2023

$8

$-2.15 (-21.18%)

$27

1 years 5 months 18 days ago
(13-May-2025)

1/4 (25%)

$0.15 (1.91%)

6

Show more analysts

Please expand the browser size to see the chart

What is ITOS (Iteos Therapeutics) average time for price targets to be met?

On average it took 104 days for the stock forecasts to be reached, with an average price target met ratio of 10.52%.

Which analyst most recently updated their price target on ITOS (Iteos Therapeutics)?

Eva Fortea Verdejo

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics)?

Eva Fortea Verdejo works at WELLS FARGO and has 13 price targets and 8 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics)?

Christopher Raymond with the highest potential upside of $25.85

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics)?

Christopher Neyor with the lowest potential downside of -$2.15
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?